Ace inhibitor fetopathy
Ace inhibitor fetopathy - fetal embryopathy associated with maternal angiotensis converting enzyme (ace) inhibitor use during pregnancy that may include fetal acute renal failure, growth restriction, oligohydramnios, calvaria abnormalities, preterm birth, and pulmonary hypoplasia with respiratory distress.
Up to date info
Latest research - Ace inhibitor fetopathy
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Ace inhibitor fetopathy for any updates.